Gene therapy develop at UCL transforms lives of people with haemophilia A
Gene therapy develop at UCL transforms lives of people with haemophilia A
A new treatment for people with haemophilia A, developed at UCL, is offering a new quality of life for people with the debilitating disease.
The technology was developed by Professor Amit Nathwani (UCL Cancer Institute and Institute of Immunity & Transplantation) and his team at UCL and St. Jude Children’s Research Hospital, USA.
It was licensed by UCL Business (UCLB), the commercialisation company for UCL, to BioMarin Pharmaceuticals Inc. in 2013.
Find out more in the case study on the UCL Innovation & Enterprise website.
Caroline May | |
62 | |
4/12/2024 | |
00:04:23 | |
innovation, commercialisation, uclb, Haemophilia | |
Download |